164 related articles for article (PubMed ID: 21984809)
1. TRIM32 promotes neural differentiation through retinoic acid receptor-mediated transcription.
Sato T; Okumura F; Kano S; Kondo T; Ariga T; Hatakeyama S
J Cell Sci; 2011 Oct; 124(Pt 20):3492-502. PubMed ID: 21984809
[TBL] [Abstract][Full Text] [Related]
2. TRIM32 promotes retinoic acid receptor α-mediated differentiation in human promyelogenous leukemic cell line HL60.
Sato T; Okumura F; Iguchi A; Ariga T; Hatakeyama S
Biochem Biophys Res Commun; 2012 Jan; 417(1):594-600. PubMed ID: 22182411
[TBL] [Abstract][Full Text] [Related]
3. The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFkappaB.
Albor A; El-Hizawi S; Horn EJ; Laederich M; Frosk P; Wrogemann K; Kulesz-Martin M
J Biol Chem; 2006 Sep; 281(35):25850-66. PubMed ID: 16816390
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the Zn-Binding Domains of TRIM32, the E3 Ubiquitin Ligase Mutated in Limb Girdle Muscular Dystrophy 2H.
Lazzari E; El-Halawany MS; De March M; Valentino F; Cantatore F; Migliore C; Onesti S; Meroni G
Cells; 2019 Mar; 8(3):. PubMed ID: 30884854
[TBL] [Abstract][Full Text] [Related]
5. TRIM32 is an E3 ubiquitin ligase for dysbindin.
Locke M; Tinsley CL; Benson MA; Blake DJ
Hum Mol Genet; 2009 Jul; 18(13):2344-58. PubMed ID: 19349376
[TBL] [Abstract][Full Text] [Related]
6. Mutations that impair interaction properties of TRIM32 associated with limb-girdle muscular dystrophy 2H.
Saccone V; Palmieri M; Passamano L; Piluso G; Meroni G; Politano L; Nigro V
Hum Mutat; 2008 Feb; 29(2):240-7. PubMed ID: 17994549
[TBL] [Abstract][Full Text] [Related]
7. TRIM32, but not its muscular dystrophy-associated mutant, positively regulates and is targeted to autophagic degradation by p62/SQSTM1.
Overå KS; Garcia-Garcia J; Bhujabal Z; Jain A; Øvervatn A; Larsen KB; Deretic V; Johansen T; Lamark T; Sjøttem E
J Cell Sci; 2019 Dec; 132(23):. PubMed ID: 31685529
[TBL] [Abstract][Full Text] [Related]
8. Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin.
Kudryashova E; Kudryashov D; Kramerova I; Spencer MJ
J Mol Biol; 2005 Nov; 354(2):413-24. PubMed ID: 16243356
[TBL] [Abstract][Full Text] [Related]
9. Limb-girdle muscular dystrophy 2H and the role of TRIM32.
Shieh PB; Kudryashova E; Spencer MJ
Handb Clin Neurol; 2011; 101():125-33. PubMed ID: 21496629
[TBL] [Abstract][Full Text] [Related]
10. Tripartite Motif-Containing Protein 32 (TRIM32): What Does It Do for Skeletal Muscle?
Jeong SY; Choi JH; Kim J; Woo JS; Lee EH
Cells; 2023 Aug; 12(16):. PubMed ID: 37626915
[TBL] [Abstract][Full Text] [Related]
11. Novel
Panicucci C; Traverso M; Baratto S; Romeo C; Iacomino M; Gemelli C; Tagliafico A; Broda P; Zara F; Bruno C; Minetti C; Fiorillo C
Acta Myol; 2019 Mar; 38(1):8-12. PubMed ID: 31309175
[TBL] [Abstract][Full Text] [Related]
12. Generation of the short TRIM32 isoform is regulated by Lys 247 acetylation and a PEST sequence.
Garcia-Garcia J; Overå KS; Khan W; Sjøttem E
PLoS One; 2021; 16(5):e0251279. PubMed ID: 33999923
[TBL] [Abstract][Full Text] [Related]
13. RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties.
Horn EJ; Albor A; Liu Y; El-Hizawi S; Vanderbeek GE; Babcock M; Bowden GT; Hennings H; Lozano G; Weinberg WC; Kulesz-Martin M
Carcinogenesis; 2004 Feb; 25(2):157-67. PubMed ID: 14578165
[TBL] [Abstract][Full Text] [Related]
14. Tripartite motif 32 prevents pathological cardiac hypertrophy.
Chen L; Huang J; Ji Y; Zhang X; Wang P; Deng K; Jiang X; Ma G; Li H
Clin Sci (Lond); 2016 May; 130(10):813-28. PubMed ID: 26884348
[TBL] [Abstract][Full Text] [Related]
15. The E3 ubiquitin ligase TRIM32 regulates myoblast proliferation by controlling turnover of NDRG2.
Mokhonova EI; Avliyakulov NK; Kramerova I; Kudryashova E; Haykinson MJ; Spencer MJ
Hum Mol Genet; 2015 May; 24(10):2873-83. PubMed ID: 25701873
[TBL] [Abstract][Full Text] [Related]
16. A patient with limb girdle muscular dystrophy carries a TRIM32 deletion, detected by a novel CGH array, in compound heterozygosis with a nonsense mutation.
Neri M; Selvatici R; Scotton C; Trabanelli C; Armaroli A; De Grandis D; Levy N; Gualandi F; Ferlini A
Neuromuscul Disord; 2013 Jun; 23(6):478-82. PubMed ID: 23541687
[TBL] [Abstract][Full Text] [Related]
17. Use of SNP array analysis to identify a novel TRIM32 mutation in limb-girdle muscular dystrophy type 2H.
Cossée M; Lagier-Tourenne C; Seguela C; Mohr M; Leturcq F; Gundesli H; Chelly J; Tranchant C; Koenig M; Mandel JL
Neuromuscul Disord; 2009 Apr; 19(4):255-60. PubMed ID: 19303295
[TBL] [Abstract][Full Text] [Related]
18. TRIM32 ubiquitin E3 ligase, one enzyme for several pathologies: From muscular dystrophy to tumours.
Lazzari E; Meroni G
Int J Biochem Cell Biol; 2016 Oct; 79():469-477. PubMed ID: 27458054
[TBL] [Abstract][Full Text] [Related]
19. TRIM32 protein sensitizes cells to tumor necrosis factor (TNFα)-induced apoptosis via its RING domain-dependent E3 ligase activity against X-linked inhibitor of apoptosis (XIAP).
Ryu YS; Lee Y; Lee KW; Hwang CY; Maeng JS; Kim JH; Seo YS; You KH; Song B; Kwon KS
J Biol Chem; 2011 Jul; 286(29):25729-38. PubMed ID: 21628460
[TBL] [Abstract][Full Text] [Related]
20. Commonality of TRIM32 mutation in causing sarcotubular myopathy and LGMD2H.
Schoser BG; Frosk P; Engel AG; Klutzny U; Lochmüller H; Wrogemann K
Ann Neurol; 2005 Apr; 57(4):591-5. PubMed ID: 15786463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
